INSIDER
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 43h ago
HOUSE PTR3h ago
SEC 13F3h ago
ROBINHOOD CHAIN3h ago
SEC FORM 4/Tax withholdingVerified data

Schmid Timothy reported JNJ

EVP, WW Chair, MedTech · JOHNSON & JOHNSON · Common Stock

Side
F
Value
$2.48M
Shares
10.3K
Price
$239.99
Executed
Feb 6, 2026
Disclosed
Feb 10, 2026
Disclosure timeline4 days from execution to publication · legal deadline 2 business days
Feb 6 executedFeb 10, 2026 disclosed

JNJ · daily

Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.

Insider Score

Experimental signal
30/ 100 · ELEVATED
Methodology →
  • Transaction type0 / 20

    Tax withholding — administrative, little informational value

  • Relative size+22 / 25

$2.5M reported value · 87.7% of prior position

  • Filing timing0 / 15

    Disclosed 2 business days after execution (deadline: 2)

  • Historical behavior+8 / 15

    First recorded trade by this actor in this security

  • Frequency & clustering0 / 15

    No clustered activity in the dataset

  • Market events0 / 10

    No material company filing within 60 days after the trade

    • The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.

    Other disclosed activity · JNJ

    ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
    16
    Thomas H. Kean, Jr.RSelf
    JNJJOHNSON & JOHNSON
    Partial sale
    		SELL$1,001 – $15KSep 30, 2026Oct 30, 2026
    traded Sep 30, 2026
    		+30dHOUSE PTR

    Evidence

    20
    Lloyd DoggettDSelf
    JNJJOHNSON & JOHNSON
    Purchase
    		BUY$1,001 – $15KSep 8, 2026Oct 5, 2026
    traded Sep 8, 2026
    		+27dHOUSE PTR

    Evidence

    16
    Thomas H. Kean, Jr.RSelf
    JNJJOHNSON & JOHNSON
    Partial sale
    		SELL$1,001 – $15KAug 27, 2026Sep 12, 2026
    traded Aug 27, 2026
    		+16dHOUSE PTR

    Evidence

    16
    RM
    Richard Dean McCormickSelf
    JNJJOHNSON & JOHNSON
    Sale
    		SELL$1,001 – $15KJul 30, 2026Aug 14, 2026
    traded Jul 30, 2026
    		+15dHOUSE PTR

    Evidence

    20
    Thomas H. Kean, Jr.RSelf
    JNJJOHNSON & JOHNSON
    Partial sale
    		SELL$1,001 – $15KJun 2, 2026Jul 15, 2026
    traded Jun 2, 2026
    		+43dHOUSE PTR

    Evidence

    16
    Thomas H. Kean, Jr.RSelf
    JNJJOHNSON & JOHNSON
    Partial sale
    		SELL$1,001 – $15KJun 29, 2026Jul 15, 2026
    traded Jun 29, 2026
    		+16dHOUSE PTR

    Evidence

    20
    Lloyd DoggettDSelf
    JNJJOHNSON & JOHNSON
    Purchase
    		BUY$1,001 – $15KJun 9, 2026Jul 6, 2026
    traded Jun 9, 2026
    		+27dHOUSE PTR

    Evidence

    21
    Thomas H. Kean, Jr.RSelf
    JNJJOHNSON & JOHNSON
    Partial sale
    		SELL$1,001 – $15KMar 26, 2026Apr 13, 2026
    traded Mar 26, 2026
    		+18dHOUSE PTR

    Evidence

    25
    RM
    Richard Dean McCormickSelf
    JNJJOHNSON & JOHNSON
    Partial sale
    		SELL$1,001 – $15KMar 19, 2026Apr 7, 2026
    traded Mar 19, 2026
    		+19dHOUSE PTR

    Evidence

    25
    RM
    Richard Dean McCormickSelf
    JNJJOHNSON & JOHNSON
    Partial sale
    		SELL$1,001 – $15KMar 19, 2026Apr 7, 2026
    traded Mar 19, 2026
    		+19dHOUSE PTR

    Evidence

    24
    Lloyd DoggettDSelf
    JNJJOHNSON & JOHNSON
    Purchase
    		BUY$1,001 – $15KMar 10, 2026Apr 6, 2026
    traded Mar 10, 2026
    		+27dHOUSE PTR

    Evidence

    24
    Thomas H. Kean, Jr.RSelf
    JNJJOHNSON & JOHNSON
    Partial sale
    		SELL$15K – $50KJan 23, 2026Feb 19, 2026
    traded Jan 23, 2026
    		+27dHOUSE PTR

    Evidence

    30
    ST
    Schmid TimothyEVP, WW Chair, MedTech
    JNJJOHNSON & JOHNSON
    Option exercise
    		M$1.59M
    15.6K sh
    		Feb 6, 2026Feb 10, 2026
    traded Feb 6, 2026
    		+4dSEC FORM 4

    Evidence

    18
    ST
    Schmid TimothyEVP, WW Chair, MedTech
    JNJJOHNSON & JOHNSON
    Option exercise
    		M$1.59M
    15.6K sh
    		Feb 6, 2026Feb 10, 2026
    traded Feb 6, 2026
    		+4dSEC FORM 4

    Evidence

    18
    FE
    Forminard ElizabethEVP, Chief Legal Officer
    JNJJOHNSON & JOHNSON
    Option exercise
    		M$1.16M
    8,921 sh
    		Feb 5, 2026Feb 6, 2026
    traded Feb 5, 2026
    		+1dSEC FORM 4

    Evidence

    30
    FE
    Forminard ElizabethEVP, Chief Legal Officer
    JNJJOHNSON & JOHNSON
    Option exercise
    		M$1.16M
    8,921 sh
    		Feb 5, 2026Feb 6, 2026
    traded Feb 5, 2026
    		+1dSEC FORM 4

    Evidence

    30
    FE
    Forminard ElizabethEVP, Chief Legal Officer
    JNJJOHNSON & JOHNSON
    Tax withholding
    		F$1.48M
    6,226 sh
    		Feb 5, 2026Feb 6, 2026
    traded Feb 5, 2026
    		+1dSEC FORM 4

    Evidence

    Evidence

    Verified data

    Read directly from the primary public document; every field below is as reported by the filer.

    Source

    Document
    SEC Form 4
    Publisher
    U.S. Securities and Exchange Commission (EDGAR)
    Document ID
    0001998491-26-000002
    Machine-readable
    Structured copy

    Timestamps

    Event (reported)
    Feb 6, 2026
    Published
    Feb 10, 2026
    Ingested by INSIDER
    Nov 5, 04:17 UTC
    Last re-read
    Nov 5, 04:17 UTC

    Extracted facts

    Filer
    Schmid Timothy
    Role
    EVP, WW Chair, MedTech
    Transaction
    Tax withholdingAs filed: “F”
    Asset
    JOHNSON & JOHNSON
    Ticker
    JNJ
    Shares
    10.3K
    Price per share
    $239.99
    Value
    $2,480,297
    Execution date (reported)
    Feb 6, 2026
    Owned after transaction
    22.1K shares
    Days from execution to publication
    4

    Calculation

    Value = shares × reported price per share

    • Shares: 10.3K
    • Price: $239.99

    = $2,480,297

    What this establishes

    Schmid Timothy filed this Form 4 reporting a tax withholding of JNJ on Feb 6, 2026. It became public on Feb 10, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

    Extraction

    Method
    Form 4 XML
    Confidence
    1.00
    EVP, WW Chair, MedTech
    Schmid Timothycik:0001998491
    Issuer
    JOHNSON & JOHNSONcik:0000200406

    Revision history · 0

    No field has changed since this record was first ingested.

    Company events

    No records

    No material filings recorded for this issuer.